SCHEMBL210371

SCHEMBL210371

Nc1nnnc(Cl)c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210649 0.77
SCHEMBL159747 0.77
SCHEMBL28872864 0.71
SCHEMBL6049955 0.67 CASP1 (0.33)
SCHEMBL13822465 0.65
SCHEMBL1316316 0.65
SCHEMBL5933484 0.65
SCHEMBL142354 0.63
Sulfurous Acid SCHEMBL5276966 0.63 CA1 (0.33)
SCHEMBL3622126 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770733-A Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained RHONE MERIEUX (FR) 1998-06-23 US claimed
US-5459263-A Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained RHONE MEREIUX (FR) 1995-10-17 US claimed
EP-0179408-B1 AMIDOALKYL MELAMINES AND AMINOALKYL MELAMINES, AND PROCESS FOR THEIR PREPARATION BASF Aktiengesellschaft (DE) 1993-09-08 EP claimed
EP-0179408-A2 Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation BASF Aktiengesellschaft (DE) 1986-04-30 EP claimed
JP-6024960-A None JP disclosed
US-20160256463-A1 NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS INC (US) 2016-09-08 US disclosed
US-9351972-B2 Compounds as respiratory stimulants for treatment of breathing control disorders or diseases GALLEON PHARMACEUTICALS, INC. (US) 2016-05-31 US disclosed
CN-103347866-B As the noval chemical compound of the respiratory stimulant for the treatment of control of breathing discomfort or disease GALLEON PHARMACEUTICALS, INC. (US) 2016-05-18 CN disclosed
US-20150374706-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS, INC. 2015-12-31 US disclosed
US-9162992-B2 Compounds and compositions for treatment of breathing control disorders or diseases GALLEON PHARMACEUTICALS, INC. (US) 2015-10-20 US disclosed
US-20150291597-A1 NOVEL ORALLY BIOAVAILABLE BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME GALLEON PHARMACEUTICALS, INC. 2015-10-15 US disclosed
EP-2920155-A2 NOVEL ORALLY BIOAVAILABLE BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME Galleon Pharmaceuticals, Inc. (US) 2015-09-23 EP disclosed
US-4886882-A URETHANE, AMINOPLAST INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1989-12-12 US disclosed
EP-0240867-A1 Process for the preparation of aminoalkyl- or -arylmelamines BASF Aktiengesellschaft (DE) 1987-10-14 EP disclosed
EP-0225433-A2 Hydroxyoxaalkyl melamines, process for their preparation and their use BASF Aktiengesellschaft (DE) 1987-06-16 EP disclosed
US-4670558-A POLYURETHANE INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1987-06-02 US disclosed
EP-0079037-B1 BIS-MELAMINES Degussa Aktiengesellschaft (DE) 1986-10-29 EP disclosed
EP-0179408-A2 Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation BASF Aktiengesellschaft (DE) 1986-04-30 EP disclosed
EP-0079774-B1 INHIBITING THE ANTAGONISM BETWEEN PYRIDYLOXYPHENOXY ALKANOATE HERBICIDES AND BENZOTHIADIAZINONE HERBICIDES IN POST-EMERGENT APPLICATIONS THE DOW CHEMICAL COMPANY (US) 1985-09-18 EP disclosed
EP-0079037-A2 Bis-melamines Degussa Aktiengesellschaft (DE) 1983-05-18 EP disclosed